PL3650024T3 - Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia - Google Patents
Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępieniaInfo
- Publication number
- PL3650024T3 PL3650024T3 PL18828851.8T PL18828851T PL3650024T3 PL 3650024 T3 PL3650024 T3 PL 3650024T3 PL 18828851 T PL18828851 T PL 18828851T PL 3650024 T3 PL3650024 T3 PL 3650024T3
- Authority
- PL
- Poland
- Prior art keywords
- rifampicins
- pharmaceutical composition
- nasal administration
- treating dementia
- dementia
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017132955 | 2017-07-06 | ||
| PCT/JP2018/025512 WO2019009359A1 (ja) | 2017-07-06 | 2018-07-05 | 経鼻投与用医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3650024T3 true PL3650024T3 (pl) | 2024-03-18 |
Family
ID=64951007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18828851.8T PL3650024T3 (pl) | 2017-07-06 | 2018-07-05 | Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11583494B2 (pl) |
| EP (1) | EP3650024B1 (pl) |
| JP (1) | JP7146281B2 (pl) |
| CN (1) | CN110831598A (pl) |
| CA (1) | CA3068690A1 (pl) |
| DK (1) | DK3650024T3 (pl) |
| ES (1) | ES2970909T3 (pl) |
| FI (1) | FI3650024T3 (pl) |
| HU (1) | HUE065421T2 (pl) |
| MX (1) | MX2020000144A (pl) |
| PL (1) | PL3650024T3 (pl) |
| PT (1) | PT3650024T (pl) |
| WO (1) | WO2019009359A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102051624B1 (ko) * | 2018-11-30 | 2019-12-02 | 아밀로이드솔루션 주식회사 | 트리플루프로마진 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 퇴행성 뇌질환 치료용 약학 조성물 |
| AU2020302992A1 (en) * | 2019-06-28 | 2022-02-03 | The Trustees Of The University Of Pennsylvania | Intranasal dantrolene administration for treatment of Alzheimer's Disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995011248A1 (fr) * | 1993-10-20 | 1995-04-27 | Teijin Limited | INHIBITEUR D'AGGLUTINATION ET/OU DE DEPOT DE LA PROTEINE β AMYLOÏDE |
-
2018
- 2018-07-05 EP EP18828851.8A patent/EP3650024B1/en active Active
- 2018-07-05 CN CN201880044459.8A patent/CN110831598A/zh active Pending
- 2018-07-05 CA CA3068690A patent/CA3068690A1/en active Pending
- 2018-07-05 US US16/628,476 patent/US11583494B2/en active Active
- 2018-07-05 DK DK18828851.8T patent/DK3650024T3/da active
- 2018-07-05 MX MX2020000144A patent/MX2020000144A/es unknown
- 2018-07-05 FI FIEP18828851.8T patent/FI3650024T3/fi active
- 2018-07-05 ES ES18828851T patent/ES2970909T3/es active Active
- 2018-07-05 JP JP2019527959A patent/JP7146281B2/ja active Active
- 2018-07-05 PL PL18828851.8T patent/PL3650024T3/pl unknown
- 2018-07-05 WO PCT/JP2018/025512 patent/WO2019009359A1/ja not_active Ceased
- 2018-07-05 HU HUE18828851A patent/HUE065421T2/hu unknown
- 2018-07-05 PT PT188288518T patent/PT3650024T/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3650024A4 (en) | 2021-04-07 |
| PT3650024T (pt) | 2023-12-14 |
| US11583494B2 (en) | 2023-02-21 |
| JP7146281B2 (ja) | 2022-10-04 |
| ES2970909T3 (es) | 2024-05-31 |
| JPWO2019009359A1 (ja) | 2020-07-27 |
| CA3068690A1 (en) | 2019-01-10 |
| WO2019009359A1 (ja) | 2019-01-10 |
| EP3650024A1 (en) | 2020-05-13 |
| HUE065421T2 (hu) | 2024-05-28 |
| MX2020000144A (es) | 2020-07-22 |
| DK3650024T3 (da) | 2023-12-04 |
| FI3650024T3 (fi) | 2023-12-12 |
| EP3650024B1 (en) | 2023-10-25 |
| CN110831598A (zh) | 2020-02-21 |
| US20200129426A1 (en) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268316B (en) | Pharmaceutical preparations for combined treatment | |
| ZA201906613B (en) | Pharmaceutical compositions for combination therapy | |
| PL3616720T3 (pl) | Kompozycja farmaceutyczna do leczenia nowotworu | |
| ZA201706007B (en) | Pharmaceutical compositions for combination therapy | |
| ZA201905510B (en) | Pharmaceutical compositions for combination therapy | |
| IL261444A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
| PL3129378T3 (pl) | Związki hamujące bromodomenę i zawierająca je kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu | |
| IL261278A (en) | Pharmaceutical compositions for the treatment of cancer | |
| IL275525A (en) | A pharmaceutical preparation for the treatment of cancer | |
| ZA201803320B (en) | Pharmaceutical compositions for treating pain | |
| SG10201912046VA (en) | Pharmaceutical composition for preventing or treating regulatory t cell-mediated diseases | |
| PL3650024T3 (pl) | Kompozycja farmaceutyczna do podawania donosowego, zawierająca ryfampicyny, do leczenia otępienia | |
| EP3338771A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF TRAMADOL-ETORICOXIB CHLORHYDRATE FOR THE TREATMENT OF PAIN | |
| PL3236961T3 (pl) | Kompozycja farmaceutyczna do zapobiegania lub leczenia nowotworu złośliwego | |
| ZA201804588B (en) | Pharmaceutical formulations for the treatment of diabetes | |
| IL252774A0 (en) | A pharmaceutical preparation for the treatment of fungus | |
| GB201621559D0 (en) | A method for the preparation of a delivery drug delivery system and a composition therefor | |
| EP3253379A4 (en) | Pharmaceutical composition for the treatment of obesity | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| HK40013349A (en) | Pharmaceutical compositions for combination therapy | |
| GB201719584D0 (en) | Pharmaceutical compositions for the treatment of cancer | |
| HUP1400084A2 (hu) | Dabigatran és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói |